Last reviewed · How we verify
NCT04499274
Ondansetron and Blood Coagulation
NA trial testing 0 ul of ondansetron in Blood Coagulation Disorder in 12 participants. Status unknown.
15 November 2023
Quick facts
| Lead sponsor | Seoul National University Bundang Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 12 |
| Start date | 16 September 2020 |
| Primary completion | 15 November 2023 |
| Estimated completion | 15 December 2023 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- 0 ul of ondansetron — full drug profile →
- 0.2 ul of ondansetron — full drug profile →
- 2 ul of ondansetron — full drug profile →
- 20 ul of ondansetron — full drug profile →
Conditions studied
- Blood Coagulation Disorder — all drugs for Blood Coagulation Disorder →
Sponsor
Seoul National University Bundang Hospital
Who can join
Adults 20 to 65, any sex, with Blood Coagulation Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Ondansetron may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of ondansetron. The investigators therefore will perform the present study to measure the effect of ondansestron on the blood coagulation pathway according to the drug concentration level using a thromboelastography test.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04499274
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Blood Coagulation Disorder
Currently open trials in the same condition.
- NCT07164300 — Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery · NA · recruiting
- NCT06403163 — Transfusion Surveillance in Anaesthesia · recruiting
- NCT03255928 — Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD) · recruiting
Other Seoul National University Bundang Hospital trials
Trials by the same sponsor.
- NCT07459725 — Comparison of EEG-Timed vs. Repetitive Robot Therapy for Chronic Stroke · NA · not yet recruiting
- NCT07455279 — Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study · not yet recruiting
- NCT07477574 — Muscle-Specific Multimodal AI for Sarcopenia Diagnosis · NA · not yet recruiting
- NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
- NCT07305662 — Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGU · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04499274 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Bundang Hospital
- Last refreshed: 15 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04499274.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing